CL's solid pricing strategies and premium innovation drive growth, but macroeconomic challenges and currency headwinds ...

Barclays analyst Lauren Lieberman lowered the firm’s price target on Colgate-Palmolive (CL) to $83 from $96 and keeps an Equal Weight rating on ...

Barclays analyst Lauren Lieberman maintained a Hold rating on Colgate-Palmolive (CL – Research Report) today and set a price target of $83.00.

BSM Partners, the largest full-service pet care research, consulting, and strategy-to-shelf product innovation firm, is ...

Pallas Capital Advisors LLC lowered its position in Colgate-Palmolive (NYSE:CL – Free Report) by 6.6% in the 4th quarter, ...

Colgate-Palmolive Co (CL) stock saw a modest uptick, ending the day at $87.67 which represents a slight increase of $0.57 or 0.65% from the prior close of $87.1. The stock opened at $87.21 and touched ...

Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our ...

Six class action complaints accuse major dental product makers of deceptively marketing products containing fluoride to young ...

There is more to the comparison, and in the sections below, we discuss why we think CL will outperform KMB in the next three ...

Colgate-Palmolive (NYSE:CL – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the twenty-two ...

Fluoride helps prevent cavities when applied topically to the teeth, but when ingested can pose significant risks, even kill ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...